This briefing provides an update on previous briefings up to 1 April 2021 Summary • There are 4 variants of concern and 7 variants under investigation (Table 1). VOC-20DEC-01 (B.1.1.7) remains predominant in the UK. Other variants of concern and variants under investigation remain a very low proportion of the available sequence data. VUI-21APR-01 (B.1.617.1) […]
This briefing provides an update on previous briefings up to 11 March 2021 Summary • There are 4 variants of concern and 6 variants under investigation (Table 1). Definitions for variants of concern, variants under investigation and signals in monitoring have been updated. VOC-20DEC-01 (B.1.1.7) remains predominant. Other variants of concern and variants under investigation […]
The world is in midst of the COVID-19 pandemic. Previously known as B.1.617.2, the variant was first discovered in India in February, where it contributed to a horrific wave of infections which started in the spring: The Economist estimates that there have been more than 1m covid deaths in India this year. The delta variant […]
Application Product Protocol Download Post Download NP antibody pair validation N002 NP antibody NP Antibody Sandwich Elisa GeneMedi’s SARS-CoV-2 NP Antibody Pair And Stability Validation with NP antigen In Sandwich ELISA Pseudovirus (PSV) Based Cell Entry PSV 293T-hACE2-01 Protocol of SARS-CoV-2 Pseudovirus(PSV)-Based Neutralization Assay 1. Validation of hACE2 overexpressionstable HEK293T cell lines 2. Genemedi-sars-cov-2 pseudovirus(psv) […]
Data Post Download The world is in midst of the COVID-19 pandemic. The first known confirmed B.1.1.529 infection was from a specimen collected on 9 November 2021. This variant has a large number of mutations, some of which are concerning. Preliminary evidence suggests an increased risk of reinfection with this variant, as compared to other […]
Table of Contents The European Medicines Agency (EMA) needs many detailed studies to confirm that a vaccine is safe, provides adequate protection and is of suitable quality. As a public-health body safeguarding medicines in the European Union (EU), EMA will only approve a vaccine for COVID-19 after a thorough evalutation demonstrating the same high standards of quality, safety […]
Technical briefing 9 This briefing provides an update on previous briefings up to 1 April 2021 Summary • There are 4 variants of concern and 7 variants under investigation (Table 1). VOC-20DEC-01 (B.1.1.7) remains predominant in the UK. Other variants of concern and variants under investigation remain a very low proportion of the available sequence […]
Technical briefing 8 This briefing provides an update on previous briefings up to 11 March 2021 Summary • There are 4 variants of concern and 6 variants under investigation (Table 1). Definitions for variants of concern, variants under investigation and signals in monitoring have been updated. VOC-20DEC-01 (B.1.1.7) remains predominant. Other variants of concern and […]
Variant of Concern 2021/03 Technical briefing 7 This briefing provides an update on previous briefings up to 13 February 2021 Summary • There are 4 variants of concern and 5 variants under investigation (Table 1) • A slightly increased risk of hospitalisation has been now been detected for VOC 202012/01 (B.1.1.7), supporting previous findings on […]
Variant of Concern 202012/01Technical briefing 6 This briefing provides an update on previous briefings up to 1 February 2021 Summary There are 4 variants of concern, designated: • VOC 202012/01 (B.1.1.7), first detected in Kent England is predominant in all regions and is circulating in multiple countries• VOC 202102/02 (B.1.1.7 cluster with E484K mutation), first detected in South West […]
